[1]巴云涛　王　权.胶质瘤组织CFL1表达水平与胶质瘤病人术后放疗效果的关系[J].中国临床神经外科杂志,2021,26(05):340-342.[doi:10.13798/j.issn.1009-153X.2021.05.007]
　BA Yun-tao,WANG Quan..Relationship between expression level of CFL1 in glioma tissues and radiotherapy outcomes of patients with glioma[J].,2021,26(05):340-342.[doi:10.13798/j.issn.1009-153X.2021.05.007]
点击复制

胶质瘤组织CFL1表达水平与胶质瘤病人术后放疗效果的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
26
期数:
2021年05期
页码:
340-342
栏目:
出版日期:
2021-05-25

文章信息/Info

Title:
Relationship between expression level of CFL1 in glioma tissues and radiotherapy outcomes of patients with glioma
文章编号:
1009-153X（2021）05-0340-03
作者:
巴云涛　王　权
450008 郑州，郑州大学附属肿瘤医院放疗科（巴云涛、王权）
Author(s):
BA Yun-tao;  WANG Quan.
Department of Radiotherapy, Henan Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou 450008, China
关键词:
胶质瘤; 丝切蛋白-1; 基因表达; 放疗; 危险因素
Keywords:
Glioma;  Expression;  Cofilin-1;  Radiosensitivity
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2021.05.007
文献标志码:
A
摘要:
目的 探讨胶质瘤组织丝切蛋白-1（cofilin-1，CFL1）表达水平与胶质瘤病人术后放疗效果的关系。方法 选择2016年12月~2018年12月接受术后放疗治疗的脑胶质瘤64例，参照实体瘤评价标准评估放疗效果：完全缓解（CR），部分缓解（PR），疾病稳定（SD），疾病进展（PD）；客观缓解率（ORR）=（CR+PR）/总例数。采用免疫组化方法检测胶质瘤组织CFL1表达水平。结果 64例中，CFL1阳性表达46例，阳性表达率为71.9%；高级别胶质瘤CFL1阳性表达率（92.3%，24/26）明显高于低级别胶质瘤（57.9%，22/38；P<0.05）。64例中，CR有14例，PR有18例，SD有22例，PD有10例；ORR为50.0%（32/64）。多因素logistic回归分析显示CFL1表达阳性是胶质瘤术后放疗效果不良的独立危险因素（P<0.05）。结论 胶质瘤CFL1表达水平随胶质瘤级别增高明增加，CFL1阳性表达是胶质瘤术后放疗效果不良的独立危险因素。
Abstract:
Objective To analyze the relationship between the expression level of cofilin-1 (CFL1) in glioma tissues and the radiotherapy outcomes of patients with glioma. Methods Sixty-four patients with glioma who received postoperative radiotherapy from December 2016 to December 2018 were collected to analyze. The effect of radiotherapy was evaluated according to the evaluation criteria of solid tumors, including complete remission (CR), partial remission (PR), stable disease (SD), and disease progression (PD). The objective response rate (ORR) was the ratio of (CR+PR) to total number of patients. Immunohistochemical method was used to detect the expression level of CFL1 in glioma tissues. Results Of 64 patients with glioma, 46 patients (71.88%) had positive expreesion of CFL1. The positive rate of CFL1 expression in patients with high-grade glioma (92.3%, 24/26) was significantly higher than that (57.9%, 22/28) in patients with low-grade glioma (P<0.05). Of 64 patients with glioma, 14 patients were CR, 18 PR, 22 SD and 10 PD. The ORR was 50.00%. Multivariate logistic regression analysis showed that CFL1 positive expression was an independent risk factor for poor radiotherapy outcomes (P<0.05). Conclusions The expression level of CFL1 in glioma increases with the grade of glioma. Positive expression of CFL1 is an independent risk factor for the poor radiotherapy outcomes of glioma patients.

参考文献/References:

[1] Ruff M, Kizilbash S, Buckner J. Further understanding of glioma mechanisms of pathogenesis: implications for thera-peutic development [J]. Expert Rev Anticanc, 2020, 20(5):355-363.
[2] Haraldseide LM, Jakola AS, Solheim O, et al. Does preoper-ative health-related quality of life predict survival in high-grade glioma patients--a prospective study [J]. Brit J Neurosurg, 2020, 34(1): 28-34.
[3] 邵骏骅，石　超，王亚倩，等. 烟曲霉COFILIN与人GOSR1蛋白相互作用并抑制HEK293T细胞的增殖[J]. 复旦学报（自然科学版），2018，57（2）：154-163，170.
[4] 左　玉，李庆伟，李莹莹. 丝切蛋白-1作为肿瘤治疗生物标记分子的作用机制[J]. 中国生物化学与分子生物学报，2018，34（9）：921-926.
[5] 《中国中枢神经系统胶质瘤诊断和治疗指南》编写组. 中国中枢神经系统胶质瘤诊断与治疗指南（2015）[J]. 中华医学杂志，2016，96（7）：485-509.
[6] Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) [J]. Eur J Cancer, 2009, 45(2): 240-247.
[7] Minhas PS, Tran S. Combination therapy of intravenouslyinjected microglia and radiation therapy prolongs survival in a rat model of spontaneous malignant glioma [J]. Int J Radiat Oncol, 2019, 104(1): 222-223.
[8] Back M, Dasantha J, David B, et al. Tumour volume reduc-tion following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma[J]. J Neuropsych Clin, 2019, 59(12): 68-74.
[9] Zhu J, Zhao YP, Zhang YQ. Low expression of FOSL1 isassociated with favorable prognosis and sensitivity to radiation/pharmaceutical therapy in lower grade glioma [J].Neurol Res, 2020, 42(6): 522-527.
[10] Fernandez-Palomo C, Seymour C, Mothersill C. Inter-relationship between low-dose hyper-radiosensitivity and radiation-induced bystander effects in the human T98G glioma and the epithelial HaCaT cell line [J]. Radiat Res, 2016, 185(2): 124-133.
[11] Chen S, Wang Y, Ni C, et al. HLF/miR-132/TTK axisregulates cell proliferation, metastasis and radiosensitivity of glioma cells [J]. Biomed Pharmcother, 2016, 83(29): 898-904.
[12] 崔守斌，姜　英，武　昕. 丝切蛋白1及前纤维蛋白1在外阴鳞状细胞癌中的表达及意义[J]. 中国医科大学学报，2015，44（1）：10-14.
[13] Sun W, Yan H, Qian C, et al. Cofilin-1 and phospho-glycerate kinase 1 as promising indicators for glioma radio-sensibility and prognosis [J]. Oncotarget, 2017, 8(33):55073-55083.
[14] Zhou T, Wang C, Yan H, et al. Inhibition of the Rac1-WAVE2-Arp2/3 signaling pathway promotes radiosensiti-vity via downregulation of cofilin-1 in U251 human glioma cells [J]. Mol Med Rep, 2016, 13(5): 4414-420.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(05):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(05):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(05):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(05):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(05):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(05):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(05):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
通讯作者：王　权，E-mail：593168007@qq.com
更新日期/Last Update: 2021-05-25